Funding · Company

Lyndra Therapeutics, Inc.

Watertown, MABiotech & Pharma

Lyndra Therapeutics, Inc. of Watertown, MA has disclosed $143M across 2 Form D offerings filed with the SEC between Jun 7, 2023 and Dec 29, 2023.

$143M

Total disclosed

Form D offerings

Offerings on file

Each amount is as reported on that filing, cumulative across its own amendments. Newest first.

$123M

Form D · Dec 29, 2023 ↗

Q4 2023 · target $206M

$20M

Form D · Jun 7, 2023 ↗

Q2 2023 · target $179M

Filing details

HeadquartersWatertown, MAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001679037Offerings on file2

Links

All SEC filings for this company ↗ lyndratherapeutics.com ↗ More biotech & pharma raises →

Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →